Rusan Pharma Private Limited has announced that its active pharmaceutical ingredient (API) manufacturing facility in Ankleshwar, Gujarat, has been granted Good Manufacturing Practice (GMP) approval by the FDA.
Abbvie’s multi-ingredient HCV treatment has been approved in the US, and following an exclusive deal with Express Scripts, could lead to a pricing war with Gilead.
